Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity

Sixth Street Partners and KKR & Co. have agreed to provide $1 billion of preferred equity to biotechnology company BridgeBio Pharma Inc., according to people with knowledge of the matter. Sixth Street Partners and KKR & Co. have agreed to provide $1 billion of preferred equity to biotechnology company BridgeBio Pharma Inc., according to people with knowledge of the matter.